SCHEMBL6947442

SCHEMBL6947442

CC(=O)OCc1ccc2ccn(C)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
ALDH1A1 P00352 2/20 0.45
CYP2A6 P11509 1/20 0.44
KDM4E B2RXH2 2/20 0.44
TP53 P04637 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
FAAH O00519 1/20 0.44
CA2 P00918 1/20 0.42
CHRNA7 P36544 1/20 0.38
IDH1 O75874 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
KDM2B Q8NHM5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945456 0.79 CYP2A6 (0.46) CYP2A6TP53FAAHCA2CHRNA7
SCHEMBL4186791 0.78 CYP3A4 (0.59) CYP3A4ALDH1A1KDM4ETP53HSD17B10
SCHEMBL29376585 0.77 BIRC5 (0.44) CYP3A4ALDH1A1KDM4ETP53HPGD
SCHEMBL16729148 0.77 BIRC5 (0.44) CYP3A4ALDH1A1KDM4ETP53HPGD
SCHEMBL14945680 0.77 CYP2A6 (0.53) CYP2A6FAAHCHRNA7MAPTL3MBTL1
SCHEMBL17316721 0.76 KDM4E (0.54) ALDH1A1CYP2A6KDM4EHPGDHSD17B10
SCHEMBL13114464 0.76 HPGD (0.55) ALDH1A1CYP2A6KDM4EHPGDFAAH
SCHEMBL28341759 0.75 MTNR1A (0.43) CYP2A6HPGDFAAHCHRNA7MAPT
SCHEMBL11320167 0.75 CYP3A4 (0.56) CYP3A4ALDH1A1KDM4ETP53HSD17B10
SCHEMBL6583538 0.75 CYP2A6 (0.49) CYP2A6HSD17B10FAAHCA2CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915872-B1 SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION HOFFMANN LA ROCHE (CH) 2003-05-14 EP disclosed
US-6030994-A ANTIPROLIFERATIVE, TUMOR AND CARCINOGENIC AGENTS; PARTICULARLY FOR TREATMENT OF SOLID TUMORS AND THOSE OF THE BREAST AND COLON HOFFMANN-LA ROCHE INC. (US) 2000-02-29 US disclosed
EP-0915872-A1 SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION F. HOFFMANN-LA ROCHE AG (CH) 1999-05-19 EP disclosed
US-5856517-A ANTIPROLIFERATIVE AGENTS USEFUL IN THE TREATMENT OF CANCER. HOFFMANN-LA ROCHE INC. (US) 1999-01-05 US disclosed
WO-1998004552-A1 SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION F. HOFFMANN-LA ROCHE AG (CH) 1998-02-05 WO disclosed